It is generally accepted that a patentee should not be entitled to protect the same invention twice (so called ‘double patenting’). However, there is nothing in the European Patent Convention (EPC) that allows the European Patent Office (EPO) to refuse an application on these grounds.
The UK Supreme Court has handed down its much anticipated decision in Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis.
Leicester City FC’s English Premier League win in 2016 was one of those riveting stories of an underdog triumphing over the odds. The club shot to prominence and the public started seeing more of the club’s trade marks and logos.
The UK government issued guidance on 24 September 2018 confirming that EU trade mark and design rights will continue to be protected in the UK in the event of a no-deal Brexit.
SMEs can apply for a share of £1.5 million to support the evaluation of innovative medical devices, diagnostics and regulated digital health products.
The UK's ratification of the Unified Patent Court Agreement has now been confirmed by Sam Gyimah, Minister for Intellectual Property.
The UK will become a contracting party to the Hague Agreement from 13th June 2018.
A developing principle in the United Kingdom and European Patent Office relates to whether the content of a patent application makes it plausible that the invention works as described.
Innovate UK will invest up to £10 million in innovation projects in medicines manufacturing to be funded through the Industrial Strategy Challenge Fund.
The theme of the 2020 conference is Sustainable Manufacturing and will discuss strategies for manufacturing products in a way that aims to reduce pollution, energy use and waste, whilst remaining commercially viable.
Although a stay of national proceedings is the ‘default’ position in the UK, the stay was refused in this instance because of the combination of an absolute right of appeal, a minimum of two years to appeal and the potential of the ping pong effect before the EPO.